or
forgot password

A Prospective Study of Endoscopic Ultrasound-guided Celiac (CB) Effectiveness


N/A
18 Years
N/A
Open (Enrolling)
Both
Chronic Pancreatitis, Pancreatic Cancer

Thank you

Trial Information

A Prospective Study of Endoscopic Ultrasound-guided Celiac (CB) Effectiveness


Inclusion Criteria:



- Patients with chronic abdominal pain from documented chronic pancreatitis or
pancreatic cancer or other visceral malignancy that are undergoing EUS-guided CB (for
purposes other than this study) will be eligible to participate in this study.

- Patients with chronic pancreatitis and pancreatic cancer must have documented disease
by CT, ERCP, or EUS.

- No evidence of dementia or altered mental status that would prohibit the giving and
understanding of informed consent, and no evidence of psychiatric risk that would
preclude adequate compliance with this protocol.

- Patient must provide signed written informed consent

Exclusion Criteria:

- Patients that have had a previous celiac plexus block are eligible for this study

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Principal Investigator

Julia LeBlanc, MD, MPH

Investigator Role:

Principal Investigator

Investigator Affiliation:

Indiana University

Authority:

United States: Institutional Review Board

Study ID:

0205-04B

NCT ID:

NCT00583271

Start Date:

June 2002

Completion Date:

June 2014

Related Keywords:

  • Chronic Pancreatitis
  • Pancreatic Cancer
  • Pancreatic Neoplasms
  • Pancreatitis
  • Pancreatitis, Chronic

Name

Location

Clarian Health: Indiana University Hospital Indianapolis, Indiana  46202